Risk assessment and outcomes of vasoplegia after cardiac surgery

General Thoracic and Cardiovascular Surgery

Volumn 65, Issue 10, 2017, Pages 557-565

  Tsiouris, Athanasios ^a,b   Wilson, Lynn ^a   Haddadin, Ala S ^a   Yun, James J ^a   Mangi, Abeel A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Providence Medical Center   (United States)

Author keywords

Cardiac surgery; Outcomes; Risk stratification; Vasoplegia

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EPINEPHRINE; METOPROLOL; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN;

ADULT; AGING; ARTICLE; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; DIALYSIS; DISEASE SEVERITY; DIURETIC THERAPY; FEMALE; HEART FAILURE; HEART INDEX; HEART INFARCTION; HEART SURGERY; HEART TRANSPLANTATION; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; LENGTH OF STAY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PULMONARY VALVULOPLASTY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL; TRICUSPID VALVE REPAIR; VASOPLEGIA; AGED; CAUSE OF DEATH; FOLLOW UP; HEART DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SURVIVAL RATE; TRENDS; UNITED STATES; VASCULAR RESISTANCE;

AGED; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES; VASCULAR RESISTANCE; VASOPLEGIA;

EID: 85020699069     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-017-0789-6     Document Type: Article

References (26)

1. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998;116(6):973–80.
2. Levin MA, Lin HM, Castillo JG, Adams DH, Reich DL, Fischer GW. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation. 2009;120(17):1664–71.
3. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61(6):1714–20.
4. Gomes WJ, Carvalho AC, Palma JH, Teles CA, Branco JN, Silas MG, et al. Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg (Torino). 1998;39(5):619–23.
5. Wan S, Marchant A, DeSmet JM, Antoine M, Zhang H, Vachiery JL, et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996;111(2):469–77.
6. Boyle EM Jr, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg. 1997;63(1):277–84.
7. Strüber M, Cremer JT, Gohrbandt B, Hagl C, Jankowski M, Völker B, et al. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg. 1999;68(4):1330–5.
8. Carrel T, Englberger L, Mohacsi P, Neidhart P, Schmidli J. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg. 2000;15(5):347–53.
9. Mekontso-Dessap A, Houël R, Soustelle C, Kirsch M, Thébert D, Loisance DY. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg. 2001;71(5):1428–32.
10. Patarroyo M, Simbaqueba C, Shrestha K, Starling RC, Smedira N, Tang WH, et al. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. J Heart Lung Transplant. 2012;31(3):282–7.
11. Alfirevic A, Xu M, Johnston D, Figueroa P, Koch CG. Transfusion increases the risk for vasoplegia after cardiac operations. Ann Thorac Surg. 2011;92(3):812–9.
12. The Congressional Research Service. Medicare hospital readmissions: issues, policy options and PPACA. Washington, DC. September 2010. INTER REF: http://www.hospitalmedicine.org/am/pdf/advocacy/crs_readmissions_report.pdf. Accessed June 2014.
13. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33(6):1266–71.
14. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113(7):e166–e286.
15. Jones CW, Pickering BT. Comparison of the effects of water deprivation and sodium chloride imbibition on the hormone content of the neurohypophysis of the rat. J Physiol. 1969;203(2):449–58.
16. Taylor KM, Bain WH, Russel M, Brannan JJ, Morton IJ. Peripheral vascular resistance and angiotensin II levels during pulsatile and no-pulsatile cardiopulmonary bypass. Thorax. 1979;34:594–8.
17. Comfere T, Sprung J, Kumar MM, Draper M, Wilson DP, Williams BA, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005;100(3):636–44.
18. Licker M, Schweizer A, Höhn L, Farinelli C, Morel DR. Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors. Can J Anaesth. 2000;47(5):433–40.
19. Booth JV, Ward EE, Colgan KC, Funk BL, El-Moalem H, Smith MP, et al; Duke heart Center Perioperative Desensitization Group. Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute beta-adrenergic receptor desensitization during cardiac surgery? Anesth Analg. 2004;98:1224–31.
20. Albright TN, Zimmerman MA, Selzman CH. Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care. 2002;11(4):326–30.
21. Dunser MW, Mayr AJ, Ulmer H. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313–9.
22. Morales DL, Garrido MJ, Madigan JD. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75(3):926–30.
23. Thiele RH, Balireddy RK, Groves DS. Methylene blue treatment for vasoplegia and resultant isoelectric processed EEG (bispectral index). J Clin Anesth. 2012;24:511–3.
24. Leyh RG, Kofidis T, Struber M. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg. 2003;125:1426–31.
25. Levin RL, Degrange MA, Bruno GF. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77:496–9.
26. Ozal E, Kuralay E, Yildirim V. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79:1615–9.